{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:38:09Z","timestamp":1785530289043,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DSE-146021"],"award-info":[{"award-number":["DSE-146021"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jaad.2023.04.035","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T19:59:17Z","timestamp":1682452757000},"page":"243-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study"],"prefix":"10.1016","volume":"89","author":[{"given":"Laurent","family":"Azoulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audray","family":"St-Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Quail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wusiman","family":"Aibibula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Wen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Eltonsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2023.04.035_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinte.167.2.141","article-title":"Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States","volume":"167","author":"Wang","year":"2007","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.1016\/j.jaad.2023.04.035_bib2","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jaad.2023.04.035_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cjco.2020.12.026","article-title":"Antihypertensive prescribing for uncomplicated, incident hypertension: opportunities for cost savings","volume":"3","author":"Quinn","year":"2021","journal-title":"CJC Open"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.035_bib4","first-page":"506","article-title":"Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.jaad.2023.04.035_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/php.12048","article-title":"Hydrochlorothiazide enhances UVA-induced DNA damage","volume":"89","author":"Kunisada","year":"2013","journal-title":"Photochem Photobiol"},{"issue":"4","key":"10.1016\/j.jaad.2023.04.035_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/joim.12629","article-title":"Hydrochlorothiazide use is strongly associated with risk of lip cancer","volume":"282","author":"Pottegard","year":"2017","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.04.035_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.04.035_bib8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","article-title":"Association of hydrochlorothiazide use and risk of malignant melanoma","volume":"178","author":"Pottegard","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.035_bib9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/bjd.16713","article-title":"Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma","volume":"179","author":"Su","year":"2018","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.04.035_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41416-019-0613-4","article-title":"Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study","volume":"121","author":"Pottegard","year":"2019","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2023.04.035_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3904\/kjim.2019.218","article-title":"Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea","volume":"35","author":"Park","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"7","key":"10.1016\/j.jaad.2023.04.035_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/bcp.14245","article-title":"Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies","volume":"86","author":"Morales","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.jaad.2023.04.035_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092910","article-title":"Association between use of hydrochlorothiazide and nonmelanoma skin cancer: common data model cohort study in asian population","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.04.035_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bcpt.13463","article-title":"Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: a population-based case-control study","volume":"127","author":"Daniels","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jaad.2023.04.035_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/ced.14520","article-title":"Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data","volume":"46","author":"Kim","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.04.035_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40264-020-01015-1","article-title":"Use of hydrochlorothiazide and risk of melanoma and nonmelanoma skin cancer","volume":"44","author":"Rouette","year":"2021","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.jaad.2023.04.035_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2020.08.025","article-title":"Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: a population-based case-control study","volume":"84","author":"Adalsteinsson","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.04.035_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jncics\/pkab009","article-title":"Risk of nonmelanoma skin cancer in association with use of hydrochlorothiazide-containing products in the United States","volume":"5","author":"Eworuke","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"10","key":"10.1016\/j.jaad.2023.04.035_bib19","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pds.5266","article-title":"Hydrochlorothiazide and risk of melanoma subtypes","volume":"30","author":"Habel","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.jaad.2023.04.035_bib20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pds.5295","article-title":"Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain","volume":"30","author":"Le\u00f3n-Mu\u00f1oz","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.035_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1186\/s12889-022-13705-9","article-title":"Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer","volume":"22","author":"VanWormer","year":"2022","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.jaad.2023.04.035_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamadermatol.2016.2609","article-title":"Application of recursive partitioning to derive and validate a claims-based algorithm for identifying keratinocyte carcinoma (nonmelanoma skin cancer)","volume":"152","author":"Chan","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.04.035_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat Med"},{"issue":"8","key":"10.1016\/j.jaad.2023.04.035_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pds.3386","article-title":"Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy","volume":"22","author":"Mack","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaad.2023.04.035_bib28","doi-asserted-by":"crossref","first-page":"l5657","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.jaad.2023.04.035_bib29","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jaad.2023.04.035_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2011.04.009","article-title":"Number needed to treat is incorrect without proper time-related considerations","volume":"65","author":"Suissa","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jaad.2023.04.035_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223007351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223007351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:22:33Z","timestamp":1759274553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223007351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0190962223007351"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.04.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}